Brokerages Anticipate Axon Enterprise Inc (AAXN) Will Post Quarterly Sales of $91.82 Million

Analysts predict that Axon Enterprise Inc (NASDAQ:AAXN) will announce $91.82 million in sales for the current quarter, according to Zacks. Four analysts have issued estimates for Axon Enterprise’s earnings. The highest sales estimate is $92.70 million and the lowest is $90.08 million. Axon Enterprise posted sales of $79.24 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 15.9%. The business is scheduled to announce its next quarterly earnings report on Tuesday, May 8th.

According to Zacks, analysts expect that Axon Enterprise will report full year sales of $91.82 million for the current financial year, with estimates ranging from $398.10 million to $405.31 million. For the next fiscal year, analysts anticipate that the company will report sales of $466.53 million per share, with estimates ranging from $457.60 million to $474.09 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that follow Axon Enterprise.

Axon Enterprise (NASDAQ:AAXN) last issued its earnings results on Tuesday, February 27th. The industrial products company reported $0.13 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.21. Axon Enterprise had a net margin of 1.59% and a return on equity of 8.17%. The firm had revenue of $94.65 million for the quarter, compared to analysts’ expectations of $87.88 million.

A number of equities analysts have issued reports on AAXN shares. Dougherty & Co reissued a “buy” rating and issued a $36.00 target price (up previously from $33.00) on shares of Axon Enterprise in a report on Wednesday, February 28th. JPMorgan Chase set a $37.00 target price on shares of Axon Enterprise and gave the stock a “buy” rating in a report on Wednesday, February 28th. Craig Hallum set a $37.00 target price on shares of Axon Enterprise and gave the stock a “buy” rating in a report on Wednesday, February 28th. Ladenburg Thalmann Financial Services raised shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $35.00 target price on the stock in a report on Wednesday, February 28th. Finally, BidaskClub cut shares of Axon Enterprise from a “strong-buy” rating to a “buy” rating in a report on Thursday, January 11th. Five investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $38.00.

Shares of NASDAQ AAXN opened at $41.84 on Friday. Axon Enterprise has a 52-week low of $20.57 and a 52-week high of $43.16. The stock has a market capitalization of $2,237.83, a price-to-earnings ratio of 154.96, a price-to-earnings-growth ratio of 4.35 and a beta of 0.78.

In other news, CRO Joshua Isner sold 9,301 shares of Axon Enterprise stock in a transaction that occurred on Friday, March 2nd. The stock was sold at an average price of $36.34, for a total transaction of $337,998.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, President Luke Larson sold 36,105 shares of Axon Enterprise stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $36.62, for a total value of $1,322,165.10. The disclosure for this sale can be found here. Insiders own 3.90% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Ashford Capital Management Inc. raised its holdings in shares of Axon Enterprise by 149.7% during the fourth quarter. Ashford Capital Management Inc. now owns 549,993 shares of the industrial products company’s stock valued at $14,575,000 after buying an additional 329,760 shares during the last quarter. MetLife Investment Advisors LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $585,000. Financial Advocates Investment Management bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $229,000. LPL Financial LLC raised its holdings in shares of Axon Enterprise by 7.1% during the fourth quarter. LPL Financial LLC now owns 27,361 shares of the industrial products company’s stock valued at $725,000 after buying an additional 1,810 shares during the last quarter. Finally, Millennium Management LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $377,000. 95.87% of the stock is currently owned by institutional investors.

WARNING: This piece of content was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3337296/brokerages-anticipate-axon-enterprise-inc-aaxn-will-post-quarterly-sales-of-91-82-million.html.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. The company operates through two segments, TASER Weapons, and Software and Sensors. It offers TASER X26P and TASER X2 smart weapons for law enforcement; consumer CEWs; and replacement cartridges and consumables, as well as performance power magazines.

Get a free copy of the Zacks research report on Axon Enterprise (AAXN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Axon Enterprise (NASDAQ:AAXN)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Brokerages Expect PotlatchDeltic  to Post $0.67 EPS
Zacks: Brokerages Expect PotlatchDeltic to Post $0.67 EPS
Zacks: Brokerages Expect BioCryst Pharmaceuticals  Will Announce Quarterly Sales of $10.20 Million
Zacks: Brokerages Expect BioCryst Pharmaceuticals Will Announce Quarterly Sales of $10.20 Million
Virtacoinplus  Price Up 175% Over Last Week
Virtacoinplus Price Up 175% Over Last Week
Sumokoin Tops One Day Trading Volume of $76,838.00
Sumokoin Tops One Day Trading Volume of $76,838.00
Entegris  Updates Q2 Earnings Guidance
Entegris Updates Q2 Earnings Guidance
PCM  Releases Quarterly  Earnings Results, Beats Estimates By $0.05 EPS
PCM Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPS


© 2006-2018 Ticker Report. Google+.